FDA Inspection 1282924 — ICE SpA
The FDA completed an inspection of ICE SpA on Dec 2, 2022 in Basaluzzo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 2, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Basaluzzo (Italy)
Additional details
Mutual Recognition Agreement (MRA)